Page 38 - Bsx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bsx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bsx Today - Breaking & Trending Today

Boston Scientific (NYSE:BSX) Given "Buy" Rating at Citigroup

Citigroup reissued their buy rating on shares of Boston Scientific (NYSE:BSX – Free Report) in a research note issued to investors on Thursday morning, Benzinga reports. Citigroup currently has a $63.00 price objective on the medical equipment provider’s stock. BSX has been the topic of a number of other research reports. Oppenheimer lifted their target […] ....

United States , Michaelf Mahoney , Boston Scientific , Resources Management Corp , Boston Scientific Corporation , Canaccord Genuity Group , Coppell Advisory Solutions , Wealth Management , Financial Services , Royal Bank , Orion Portfolio Solutions , Free Report , Genuity Group , Moderate Buy , Get Free Report , Portfolio Solutions , Advisory Solutions , Management Corp , Scientific Corporation , Boston Scientific Daily , Nyse Bsx , Reiterated Rating , Citigroup Inc ,

Boston Scientific Co. (NYSE:BSX) Shares Bought by Dubuque Bank & Trust Co.

Dubuque Bank & Trust Co. increased its stake in Boston Scientific Co. (NYSE:BSX – Free Report) by 7.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,488 shares of the medical equipment provider’s stock after purchasing an additional 376 shares during the […] ....

United States , Stifel Nicolaus , Wendy Carruthers , Joseph Michael Fitzgerald , Forum Financial Management , Dubuque Bank Trust Co , Boston Scientific Corporation , Koss Olinger Consulting , Royal Bank , Quent Capital , Boston Scientific , Securities Exchange Commission , Boston Scientific Co , Bergankdv Wealth Management , Clearstead Advisors , Dubuque Bank , Free Report , Olinger Consulting , Financial Management , Get Free Report , Michael Fitzgerald , Scientific Corporation , Visit Holdingschannel , Boston Scientific Daily , Nyse Bsx , Sec Filings ,

Boston Scientific (NYSE:BSX) Receives Buy Rating from Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of Boston Scientific (NYSE:BSX – Free Report) in a research note released on Wednesday morning, Benzinga reports. Needham & Company LLC currently has a $61.00 price objective on the medical equipment provider’s stock. BSX has been the topic of several other reports. Morgan Stanley started […] ....

United States , Raymond James , Wendy Carruthers , Joseph Michael Fitzgerald , Boston Scientific Corporation , Morgan Stanley , Sunbelt Securities Inc , Needham Company , Boston Scientific , Wealth Advisors , Asset Dedication , Householder Group Estate Retirement Specialist , Free Report , Moderate Buy , Scientific Stock Down , Get Free Report , Michael Fitzgerald , Group Estate , Retirement Specialist , Sunbelt Securities , Scientific Corporation , Boston Scientific Daily , Nyse Bsx , Reiterated Rating , Needham Amp Company Llc ,

Boston Scientific (NYSE:BSX) Issues FY 2023 Earnings Guidance

Boston Scientific (NYSE:BSX – Get Free Report) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided earnings per share guidance of $1.96-$2.00 for the period, compared to the consensus earnings per share estimate of $1.99. The company issued revenue guidance of $14.00 billion-$14.00 billion, compared to the consensus revenue […] ....

United States , Robertw Baird , Wendy Carruthers , Joseph Michael Fitzgerald , Securities Exchange Commission , Acadian Asset Management , Royal Bank , Boston Scientific Corporation , Prudential Plc , Sequoia Financial Advisors , Boston Scientific , International Assets Investment Management , Boston Scientific Company Profile , Get Free Report , Moderate Buy , Michael Fitzgerald , Exchange Commission , Assets Investment Management , Asset Management , Investment Advisers , Scientific Corporation , Boston Scientific Daily , Nyse Bsx ,

Boston Scientific (NYSE:BSX) Price Target Increased to $60.00 by Analysts at Barclays

Boston Scientific (NYSE:BSX – Get Free Report) had its target price boosted by Barclays from $59.00 to $60.00 in a report released on Friday, FlyOnTheWall reports. Barclays‘s target price suggests a potential upside of 11.15% from the company’s previous close. Several other research analysts have also commented on the stock. TheStreet upgraded shares of Boston […] ....

United States , Piper Sandler , Wendy Carruthers , Ltd Zurich , Boston Scientific Corporation , Geode Capital Management , Boston Scientific , Moneta Group Investment Advisors , Bank Julius Baer Co , Get Free Report , Scientific Trading Down , Julius Baer , Street Corp , Capital Management , Zentral Genossenschafts Bank Frankfurt , Group Investment Advisors , Scientific Corporation , Boston Scientific Daily , Nyse Bsx , Boost Price Target , Barclays Plc ,